These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35099784)

  • 1. Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children's Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems.
    Crabtree TSJ; Choudhary P; Lumb A; Hammond P; McLay A; Campbell F; Ng SM; Wilmot EG; Hussain S
    Diabetes Ther; 2022 Feb; 13(2):341-353. PubMed ID: 35099784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.
    Lewis DM; Hussain S
    Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey.
    Huhndt A; Chen Y; O'Donnell S; Cooper D; Ballhausen H; Gajewska KA; Froment T; Wäldchen M; Lewis DM; Raile K; Skinner TC; Braune K
    Front Clin Diabetes Healthc; 2022; 3():876511. PubMed ID: 36992765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to uptake of Open-Source automated insulin delivery Systems: Analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from the OPEN survey.
    O'Donnell S; Cooper D; Chen Y; Ballhausen H; Lewis DM; Froment T; Anna Gajewska K; Tappe A; Skinner T; Cleal B; Braune K
    Diabetes Res Clin Pract; 2023 Mar; 197():110235. PubMed ID: 36581143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.
    Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B
    J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning challenges of healthcare professionals supporting open-source automated insulin delivery.
    Crocket H; Lewis DM; Burnside M; Faherty A; Wheeler B; Frewen C; Lever C; Jefferies C; Williman J; Sanders O; Wilson R; Paul R; Price S; Jones S; de Bock M
    Diabet Med; 2022 May; 39(5):e14750. PubMed ID: 34826158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare Professionals' Knowledge of and Attitudes Towards the Use of Time in Range in Diabetes Management: Online Survey Across Seven Countries.
    De Block C; Cheng AYY; Christensen TB; Patted URH; Ginovker A
    Diabetes Ther; 2023 Aug; 14(8):1399-1413. PubMed ID: 37332055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current provision and HCP experiences of remote care delivery and diabetes technology training for people with type 1 diabetes in the UK during the COVID-19 pandemic.
    Forde H; Choudhary P; Lumb A; Wilmot E; Hussain S
    Diabet Med; 2022 Apr; 39(4):e14755. PubMed ID: 34862815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Care Provider Knowledge and Perceptions of FDA-Approved and Do-It-Yourself Automated Insulin Delivery.
    Murray JA; Clayton MF; Litchman ML
    J Diabetes Sci Technol; 2020 Nov; 14(6):1017-1021. PubMed ID: 31876176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-source automated insulin delivery systems and formal healthcare: A qualitative study of challenges in the interaction between service-users with type 1 diabetes and healthcare professionals.
    Raimond LH; O'Donnell S; Bøggild-Damkvist T; Filges T; Lomborg K
    Chronic Illn; 2023 Dec; 19(4):836-847. PubMed ID: 36437583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical Guidance for Healthcare Providers on Collaborating with People with Type 2 Diabetes: Advancing Treatment and Initiating Injectable Therapy.
    Boeder S; Matamoros D; Mansy C
    Diabetes Ther; 2023 Feb; 14(2):425-446. PubMed ID: 36520406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key Strategies for Overcoming Psychological Insulin Resistance in Adults with Type 2 Diabetes: The UK Subgroup in the EMOTION Study.
    Balogh EG; Perez-Nieves M; Cao D; Hadjiyianni II; Ashraf N; Desai U; Snoek FJ; Sturt JA
    Diabetes Ther; 2020 Aug; 11(8):1735-1744. PubMed ID: 32562245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.
    Jennings P; Hussain S
    J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review.
    Knoll C; Peacock S; Wäldchen M; Cooper D; Aulakh SK; Raile K; Hussain S; Braune K
    Diabet Med; 2022 May; 39(5):e14741. PubMed ID: 34773301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes Management.
    Forlenza GP; Tabatabai I; Lewis DM
    Diabetes Technol Ther; 2024 May; ():. PubMed ID: 38669472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
    Sherr JL; Heinemann L; Fleming GA; Bergenstal RM; Bruttomesso D; Hanaire H; Holl RW; Petrie JR; Peters AL; Evans M
    Diabetologia; 2023 Jan; 66(1):3-22. PubMed ID: 36198829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open source automated insulin delivery: addressing the challenge.
    Oliver N; Reddy M; Marriott C; Walker T; Heinemann L
    NPJ Digit Med; 2019; 2():124. PubMed ID: 31840095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.